🔥 9 High-Growth, Long-Lasting Multibagger Stocks to Add to Your Portfolio in 2025
Are you looking to invest in high-quality companies with the potential to generate multibagger returns over the next decade? The Indian stock market is full of hidden gems that, with the right vision, can multiply wealth many times over.
In this article, we explore 9 fundamentally strong, high-growth stocks across various sectors that have the potential to become the next generation of multibaggers in India. These companies offer robust earnings visibility, market leadership, and innovation-driven growth models — ideal for long-term investors.
1️⃣ Deepak Nitrite Ltd – The Chemical Multibagger
Sector: Specialty Chemicals
Why It’s a Buy:
Deepak Nitrite has emerged as a leader in intermediates, fine chemicals, and performance products. The company benefits from:
- India’s China+1 policy in chemicals
- Strategic backward integration
- Rising global demand for phenol, acetone, and nitration products
Financials at a Glance (FY24):
- Revenue: ₹7,200 Cr
- Net Profit: ₹1,160 Cr
- ROE: 28%
Future Catalyst:
With expansion plans in performance chemicals and phenol capacity, Deepak Nitrite remains a strong compounder for the next 5–10 years.
2️⃣ Tanla Platforms Ltd – Powering India’s Communication Tech
Sector: Cloud Communication & CPaaS
Why It’s a Buy:
Tanla is a leader in A2P messaging, blockchain-based communication security, and CPaaS platforms. The company counts big names like Vodafone and Airtel as clients.
Growth Drivers:
- Government’s focus on digital communication
- Wisely platform adoption
- Increasing enterprise demand for secure and scalable communication
Key Metrics (FY24):
- Revenue: ₹3,300 Cr
- Net Profit: ₹470 Cr
- PAT CAGR (5Y): 42%
Tanla is well-placed to grow with India’s booming digital ecosystem.
3️⃣ Supriya Lifescience Ltd – The Global Pharma Ingredient Supplier
Sector: Pharmaceuticals – API
Why It’s a Buy:
Supriya Lifescience is one of the largest exporters of antihistamines and vitamins. The company focuses on niche, high-margin APIs and exports to over 85 countries.
Highlights:
- High EBITDA margin (>28%)
- Zero-debt company
- Strong pipeline of 30+ DMFs
As global pharma outsourcing grows, Supriya is well-positioned to be a reliable supplier.
4️⃣ Clean Science and Technology Ltd – The Green Chemistry Giant
Sector: Specialty Chemicals
Why It’s a Buy:
This Pune-based company makes environmentally-friendly specialty chemicals used in cosmetics, FMCG, pharma, and agrochemicals.
Strengths:
- Zero-waste manufacturing
- High ROCE (40%+)
- Debt-free balance sheet
Their cutting-edge green chemistry model is attracting global clients and ESG-conscious investors.
5️⃣ Mankind Pharma Ltd – A Consumer-Focused Pharma Play
Sector: Pharmaceuticals & Consumer Healthcare
Why It’s a Buy:
Mankind combines a strong pharma portfolio with mass-market OTC brands like Manforce, Prega News, and Unwanted-72.
Key Strengths:
- Pan-India distribution
- Asset-light manufacturing
- Strong double-digit growth in both prescription and OTC segments
Mankind’s trusted brand and rural penetration make it one of the best long-term bets in healthcare.
6️⃣ BASF India Ltd – The Specialty Chemicals Powerhouse
Sector: Agrochemicals, Nutrition, Coatings
Why It’s a Buy:
A part of the German BASF Group, the Indian arm focuses on agriculture, nutrition, performance materials, and industrial solutions.
Strengths:
- Strong R&D support from parent company
- Diversified product portfolio
- ESG-compliant production
BASF India is a stable compounder with global linkage and strong growth in agro and materials sciences.
7️⃣ Cantabil Retail India Ltd – The Fashion Retail Challenger
Sector: Retail – Apparel
Why It’s a Buy:
Cantabil is one of the fastest-growing domestic apparel brands with over 500 stores in Tier-2 and Tier-3 cities.
Competitive Advantages:
- Affordable pricing
- In-house manufacturing
- Growing brand recognition in smaller cities
As India’s aspirational middle class grows, Cantabil’s value-for-money proposition will drive scale and profitability.
8️⃣ Shivalik Bimetal Controls Ltd – Precision Engineering at Its Best
Sector: Specialty Engineering / Bimetals
Why It’s a Buy:
A global leader in bimetallic strips and shunt resistors, Shivalik’s products are used in EVs, smart meters, and electrical devices.
Growth Triggers:
- Electrification of vehicles
- Smart grid expansion
- High entry barriers due to niche technology
This smallcap has high export dependency and benefits directly from global electrification megatrends.
9️⃣ Dr. Agarwal’s Eye Hospital Ltd – Vision Care Multibagger
Sector: Healthcare – Eye Care
Why It’s a Buy:
Dr. Agarwal’s has built a strong chain of super-specialty eye hospitals across India and Africa. With over 100 centers, it is aggressively expanding through organic growth and acquisitions.
Growth Drivers:
- Rising need for advanced eye care
- Low penetration of ophthalmology services
- Increasing awareness in rural and Tier-2 cities
With strategic private equity backing and a scalable model, it’s poised to become the Apollo Hospitals of Indian eye care.
🧠 Why These 9 Stocks Can Be Multibaggers
All these companies have four critical ingredients of multibagger potential:
| Criteria | Presence in These Stocks |
|---|---|
| ✔ Strong Revenue Visibility | Most have multi-year contracts or brand pull |
| ✔ High ROE / ROCE | Clean Science, Deepak Nitrite, Tanla, Shivalik |
| ✔ Industry Tailwinds | EVs, healthcare, clean energy, smart communication |
| ✔ Scalable Business Model | Retail, APIs, CPaaS, bimetals |
By diversifying across chemicals, pharma, tech, retail, and healthcare, you lower risk while maximizing long-term growth.
🧳 Ideal Portfolio Allocation (2025–2030 Vision)
| Stock Name | Suggested Allocation |
|---|---|
| Deepak Nitrite | 15% |
| Tanla Platforms | 10% |
| Supriya Lifescience | 10% |
| Clean Science | 10% |
| Mankind Pharma | 10% |
| BASF India | 10% |
| Cantabil Retail | 10% |
| Shivalik Bimetal | 10% |
| Dr. Agarwal’s Eye Hospital | 15% |
💡 Final Thoughts
In the dynamic world of investing, identifying stocks with sustainable competitive advantages is key. The nine companies listed above offer not just high growth potential, but also resilience, scalability, and profitability — ideal ingredients for multibagger performance.
These are not overnight bets but long-term wealth creators. If you’re building a portfolio with a 2025–2035 horizon, these companies deserve a serious look.
Special Offer – Get Free Access to Stock Recommendations!
When you open your Demat account through our exclusive referral link, you also get FREE lifetime access to our premium stock recommendation group.
This group is managed by SEBI-registered research analysts, offering:
- Multibagger Stock Recommendations
- Real-Time Buy/Sell Alerts
- Weekly Review & Strategy Updates
- Risk-managed and research-backed calls
Normally Charged At:
- ₹999/month
- ₹4999/year
Yours FREE when you trade through the Bloom account opened via our link.
How to Claim:
- Open account through our link:
https://live.meon.co.in/acagarwal/individual_rm?YnJhbmNoX3JlZmVyZW5jZV9jb2RlPTQ2OTczNQ== - Send WhatsApp to 7278480128 with:
- Name
- Mobile Number
- Registration Date
- Screenshot of Demat Opening
- Start getting real-time stock insights & portfolio support!
Note: You must trade from the same account to remain eligible.
🚨 Disclaimer
This article is for informational and educational purposes only. It does not constitute financial advice or a recommendation. Always consult a SEBI-registered investment advisor before making any investment decision. The author is not responsible for any gains or losses arising from the use of this content.
